Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 94 articles: HTML format

Single Articles

April 2023
1. MORGAN RB, Dhiman A, Sood D, Ong CT, et al
   Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
   J Surg Oncol. 2023;127:831-840.
   PubMed     Abstract available
   
   
   
2. FLEMING AM, Deschner BW, Williard FW, Drake JA, et al
   Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
   J Surg Oncol. 2023;127:815-822.
   PubMed     Abstract available
   
   
   
3. VAN KOOTEN RT, Ravensbergen CJ, van Buseck SCD, Grootjans W, et al
   Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
   J Surg Oncol. 2023;127:823-830.
   PubMed     Abstract available
   
   
   
4. HANSDOTTER P, Scherman P, Nikberg M, Petersen SH, et al
   Treatment and survival of patients with metachronous colorectal lung metastases.
   J Surg Oncol. 2023;127:806-814.
   PubMed     Abstract available
   
   
   
5. KERAMATI MR, Meshkati Yazd SM, Shahriarirad R, Ahmadi Tafti SM, et al
   Hand-sewn direct repair versus resection and hand-sewn anastomosis techniques for the reversal of diverting loop ileostomy after lower anterior rectal resection surgery: A randomized clinical trial.
   J Surg Oncol. 2023;127:798-805.
   PubMed     Abstract available
   
   
   March 2023
6. SHAIKH CF, Woldesenbet S, Munir MM, Moazzam Z, et al
   Association between the environmental quality index and textbook outcomes among Medicare beneficiaries undergoing surgery for colorectal cancer (CRC).
   J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27229.
   PubMed     Abstract available
   
   
   
7. TREASURE T, Macbeth F
   Finding that outcomes after imaging-guided thermal ablation and surgery for colorectal lung metastases are similar does not prove a survival benefit from either.
   J Surg Oncol. 2023;127:510-512.
   PubMed    
   
   
   
8. HANNA DN, Macfie R, Ghani MO, Hermina A, et al
   A total neoadjuvant chemotherapy approach is associated with improved recurrence-free survival in patients with colorectal peritoneal metastases undergoing cytoreductive surgery and HIPEC.
   J Surg Oncol. 2023;127:442-449.
   PubMed     Abstract available
   
   
   
9. EDWARDS MURPHY A, Earley H, Creavin B, McCullough P, et al
   A palliative stent for an acute large bowel obstruction-A video vignette.
   J Surg Oncol. 2023;127:441.
   PubMed    
   
   
   
10. SEUX H, Gignoux B, Blanchet MC, Frering V, et al
    Ambulatory colectomy for cancer: Results from a prospective bicentric study of 177 patients.
    J Surg Oncol. 2023;127:434-440.
    PubMed     Abstract available
    
    
    
11. MANGIERI CW, Valenzuela CD, Solsky IB, Erali RA, et al
    Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
    J Surg Oncol. 2023;127:450-456.
    PubMed     Abstract available
    
    
    
12. NEARY C, O'Brien L, McCormack E, Kelly M, et al
    Defining a textbook outcome for the resection of colorectal liver metastases.
    J Surg Oncol. 2023;127:616-624.
    PubMed     Abstract available
    
    
    
13. PARK SY, Park JS, Kim HJ, Kim JG, et al
    Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi-institutional retrospective analysis.
    J Surg Oncol. 2023;127:668-677.
    PubMed     Abstract available
    
    
    February 2023
14. ALAIMO L, Moazzam Z, Woldesenbet S, Lima HA, et al
    Artificial intelligence to investigate predictors and prognostic impact of time to surgery in colon cancer.
    J Surg Oncol. 2023 Feb 25. doi: 10.1002/jso.27224.
    PubMed     Abstract available
    
    
    
15. KHAN H, Radomski SN, Siddiqi A, Zhou N, et al
    Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    J Surg Oncol. 2023 Feb 15. doi: 10.1002/jso.27207.
    PubMed     Abstract available
    
    
    January 2023
16. KHAMZINA S, Lee J, Ryoo SB, Kim MJ, et al
    Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20-year single-center experience & propensity-score matching.
    J Surg Oncol. 2023;127:119-131.
    PubMed     Abstract available
    
    
    December 2022
17. AIKEN T, Hu CY, Uppal A, Francescatti AB, et al
    Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis.
    J Surg Oncol. 2022 Dec 15. doi: 10.1002/jso.27175.
    PubMed     Abstract available
    
    
    
18. VALENZUELA CD, Moaven O, Gawdi R, Stauffer JA, et al
    Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC).
    J Surg Oncol. 2022;126:1242-1252.
    PubMed     Abstract available
    
    
    
19. KIMURA J, Sui K, Murokawa T, Tabuchi M, et al
    Reconsideration of indications for third hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2022;126:1232-1241.
    PubMed     Abstract available
    
    
    
20. NAFFOUJE SA, Manguso N, Imanirad I, Sahin IH, et al
    Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
    J Surg Oncol. 2022;126:1219-1231.
    PubMed     Abstract available
    
    
    
21. LEE KC, Zhao B, Pianka K, Liu S, et al
    Current trends in nonoperative management for rectal adenocarcinoma: An unequal playing field?
    J Surg Oncol. 2022;126:1504-1511.
    PubMed     Abstract available
    
    
    
22. FENG Q, Tang W, Zhang Z, Wei Y, et al
    Robotic versus laparoscopic abdominoperineal resections for low rectal cancer: A single-center randomized controlled trial.
    J Surg Oncol. 2022;126:1481-1493.
    PubMed     Abstract available
    
    
    November 2022
23. MALHOTRA G, Lafaro K, Konstantinidis I, Melstrom L, et al
    Tumor extent impacts survival benefit in minimally invasive colectomy for T4 colon cancer: A propensity matched national cohort analysis.
    J Surg Oncol. 2022 Nov 28. doi: 10.1002/jso.27162.
    PubMed     Abstract available
    
    
    
24. KARAM E, Tabutin M, Dupre A
    Neither surveillance nor treatment showed significant survival benefit for lung metastases from colorectal cancer, imaging guided thermal ablation is a safe and efficient alternative to surgery.
    J Surg Oncol. 2022 Nov 17. doi: 10.1002/jso.27148.
    PubMed    
    
    
    
25. AYLWARD C, Noori J, Tyrrell J, O'sullivan N, et al
    Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: A systematic review.
    J Surg Oncol. 2022 Nov 9. doi: 10.1002/jso.27139.
    PubMed     Abstract available
    
    
    October 2022
26. RUBINSTEIN JC, Foroughi Pour A, Zhou J, Sheridan TB, et al
    Deep learning image analysis quantifies tumor heterogeneity and identifies microsatellite instability in colon cancer.
    J Surg Oncol. 2022 Oct 17. doi: 10.1002/jso.27118.
    PubMed     Abstract available
    
    
    
27. PATY PB, Garcia-Aguilar J
    Colorectal cancer.
    J Surg Oncol. 2022;126:881-887.
    PubMed     Abstract available
    
    
    September 2022
28. KARAM E, Tabutin M, Mastier C, Crignis L, et al
    Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
    J Surg Oncol. 2022 Sep 28. doi: 10.1002/jso.27108.
    PubMed     Abstract available
    
    
    
29. ULANJA MB, Ntafam C, Beutler BD, Antwi-Amoabeng D, et al
    Race, age, and sex differences on the influence of obesity on colorectal cancer sidedness and mortality: A national cross-sectional study.
    J Surg Oncol. 2022 Sep 16. doi: 10.1002/jso.27096.
    PubMed     Abstract available
    
    
    
30. WAGMAN LD, Geller DA, Jacobs SA, Petrelli NJ, et al
    NSABP FC-6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild-type liver metastases receiving mFOLFOX7 plus cetuximab.
    J Surg Oncol. 2022 Sep 16. doi: 10.1002/jso.27078.
    PubMed     Abstract available
    
    
    
31. WALKER BS, Billingsley KG, Sutton TL, Kolbeck KJ, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
    J Surg Oncol. 2022;126:513-522.
    PubMed     Abstract available
    
    
    
32. EMILE SH, Madbouly KM, Elfeki H, Shalaby M, et al
    Multicenter validation of the PREDICT score for prediction of local recurrence after total mesorectal excision of rectal cancer.
    J Surg Oncol. 2022;126:772-780.
    PubMed     Abstract available
    
    
    
33. SOBRADO LF, Nahas CSR, Marques CFS, Sobrado CW, et al
    Pretreatment colostomy in patients with anal squamous cell carcinoma: Risk factors for a permanent stoma.
    J Surg Oncol. 2022;126:740-747.
    PubMed     Abstract available
    
    
    
34. HAYES IP, Milanzi E, Pelly RM, Gibbs P, et al
    T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.
    J Surg Oncol. 2022;126:728-739.
    PubMed     Abstract available
    
    
    August 2022
35. SHARON CE, Song Y, Straker RJ 3rd, Kelly N, et al
    Impact of the affordable care act's medicaid expansion on presentation stage and perioperative outcomes of colorectal cancer.
    J Surg Oncol. 2022 Aug 19. doi: 10.1002/jso.27070.
    PubMed     Abstract available
    
    
    
36. GAWDI R, Valenzuela CD, Moaven O, Stauffer JA, et al
    Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    J Surg Oncol. 2022;126:339-347.
    PubMed     Abstract available
    
    
    
37. GUGUSHEFF J, White K, Fitzadam S, Creighton N, et al
    Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer.
    J Surg Oncol. 2022;126:322-329.
    PubMed     Abstract available
    
    
    July 2022
38. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Reply to Comment on "Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
    J Surg Oncol. 2022 Jul 29. doi: 10.1002/jso.27037.
    PubMed    
    
    
    
39. ZOU M, Xu M, Wu WQ, Gao F, et al
    Comment on "Risk factors for metachronous peritonealcarcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
    J Surg Oncol. 2022 Jul 29. doi: 10.1002/jso.27001.
    PubMed    
    
    
    
40. DUMONT F, Loaec C, Wernert R, Maurel B, et al
    Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control.
    J Surg Oncol. 2022 Jul 2. doi: 10.1002/jso.26990.
    PubMed     Abstract available
    
    
    
41. VAZ DA SILVA DG, Bredt LC, Diniz AL, Vieira VHR, et al
    Brazilian Society of Surgical Oncology surgical standards for resectable colorectal cancer liver metastases.
    J Surg Oncol. 2022;126:28-36.
    PubMed     Abstract available
    
    
    
42. GUMIERO JL, Oliveira BMS, Neto PAO, Pandini RV, et al
    Timing of resection of synchronous colorectal liver metastasis: A systematic review and meta-analysis.
    J Surg Oncol. 2022;126:175-188.
    PubMed     Abstract available
    
    
    June 2022
43. GRANT RRC, Khan TM, Gregory SN, Coakley BA, et al
    Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis.
    J Surg Oncol. 2022 Jun 14. doi: 10.1002/jso.26970.
    PubMed     Abstract available
    
    
    
44. JIN L, Hu Q, Sun Y
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Jun 7. doi: 10.1002/jso.26886.
    PubMed    
    
    
    
45. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer.
    J Surg Oncol. 2022 Jun 4. doi: 10.1002/jso.26975.
    PubMed     Abstract available
    
    
    
46. HU Q, Zhu KF, Sun J
    Preoperative c-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
    J Surg Oncol. 2022 Jun 2. doi: 10.1002/jso.26927.
    PubMed    
    
    
    
47. WU J, Huang Z
    Reply to the comments on "Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer".
    J Surg Oncol. 2022 Jun 2. doi: 10.1002/jso.26968.
    PubMed    
    
    
    
48. SUGARBAKER PH, Ghabra S
    Protocols versus practice in the management of colorectal peritoneal metastases.
    J Surg Oncol. 2022;125:1200-1201.
    PubMed    
    
    
    
49. SUTTON TL, Wong LH, Walker BS, Dewey EN, et al
    Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
    J Surg Oncol. 2022;125:1260-1268.
    PubMed     Abstract available
    
    
    May 2022
50. CUIJPERS ACM, Lubbers T, van Rens HA, Smit-Fun V, et al
    The patient perspective on the preoperative colorectal cancer care pathway and preparedness for surgery and postoperative recovery-a qualitative interview study.
    J Surg Oncol. 2022 May 17. doi: 10.1002/jso.26920.
    PubMed     Abstract available
    
    
    
51. YAN XL, Wang K, Bao Q, Wang HW, et al
    Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
    J Surg Oncol. 2022;125:1002-1012.
    PubMed     Abstract available
    
    
    
52. MASSUCCO P, Fontana AP, Balbo Mussetto A, Desana B, et al
    MRI-detected extramural vascular invasion (mrEMVI) as the best predictive factor to identify candidates to total neoadjuvant therapy in locally advanced rectal cancer.
    J Surg Oncol. 2022;125:1024-1031.
    PubMed     Abstract available
    
    
    
53. HAN J, Wang X, Zhang C, Wu Q, et al
    Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases.
    J Surg Oncol. 2022;125:991-1001.
    PubMed     Abstract available
    
    
    April 2022
54. HAYES IP, Milanzi E, Gibbs P, Faragher I, et al
    Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?
    J Surg Oncol. 2022 Apr 28. doi: 10.1002/jso.26913.
    PubMed     Abstract available
    
    
    
55. JULIO C, Benoist S, Allard MA, Navarro F, et al
    Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer.
    J Surg Oncol. 2022 Apr 9. doi: 10.1002/jso.26885.
    PubMed     Abstract available
    
    
    
56. SUGARBAKER PH, Chang D
    Revised prognostic indicators for treatment of lymph node positive colorectal peritoneal metastases.
    J Surg Oncol. 2022;125:889-900.
    PubMed     Abstract available
    
    
    
57. MADBOULY KM, Emile SH, Gamal AA
    Transanal total mesorectal excision (TaTME) with delayed coloanal anastomosis versus TaTME with immediate coloanal anastomosis and temporary diversion in middle and low rectal cancer.
    J Surg Oncol. 2022;125:865-871.
    PubMed     Abstract available
    
    
    March 2022
58. CHEN P, Hu Q, Sun Y
    Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26849.
    PubMed    
    
    
    
59. HU Q, Sun Y, Yang X
    Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26837.
    PubMed    
    
    
    
60. HU Q, Sun YS, Yang XY
    What are the factors predictive of postoperative complications in patients with colorectal cancer undergoing stenting as a bridge to surgery?
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26824.
    PubMed    
    
    
    
61. CUIJPERS ACM, Bongers BC, Stassen PS, Lubbers T, et al
    Reply letter to the editor: Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Mar 29. doi: 10.1002/jso.26878.
    PubMed    
    
    
    
62. ZORRILLA-VACA A, Ripolles-Melchor J, Abad-Motos A, Mingu IR, et al
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Mar 2. doi: 10.1002/jso.26836.
    PubMed     Abstract available
    
    
    
63. MEI F, Yang X, Na L, Yang L, et al
    Anal preservation on the psychology and quality of life of low rectal cancer.
    J Surg Oncol. 2022;125:484-492.
    PubMed     Abstract available
    
    
    
64. HREBINKO KA, Reitz KM, Mohammed MK, Nassour I, et al
    Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.
    J Surg Oncol. 2022;125:475-483.
    PubMed     Abstract available
    
    
    
65. SHANNON AB, Straker RJ, Keele L, Kelz RR, et al
    The impact of hospital volume on racial disparities in resected rectal cancer.
    J Surg Oncol. 2022;125:465-474.
    PubMed     Abstract available
    
    
    
66. HE S, Liu Z, Li L, Zhang J, et al
    Improvement of low anterior resection syndrome beyond 2 years after total mesorectal excision.
    J Surg Oncol. 2022;125:448-456.
    PubMed     Abstract available
    
    
    
67. JAGANMURUGAN R, Kazi M, Sukumar V, Gori J, et al
    Bladder preserving robotic pelvic exenteration for locally advanced rectal cancer-technique and short-term outcomes.
    J Surg Oncol. 2022;125:493-497.
    PubMed     Abstract available
    
    
    
68. FERRAL H, Alonzo MJ, Datri J, Hogg ME, et al
    Endovascular management of portal vein obstruction in hepatobiliary cancer patients.
    J Surg Oncol. 2022;125:392-398.
    PubMed     Abstract available
    
    
    
69. NI K, Zhan Y, Liu Z, Zhao XZ, et al
    Mismatch repair system deficiency is associated with chemoradiotherapy resistance in locally advanced rectal adenocarcinoma patients.
    J Surg Oncol. 2022;125:692-702.
    PubMed     Abstract available
    
    
    
70. MANGIERI CW, Moaven O, Valenzuela CD, Erali RA, et al
    Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery.
    J Surg Oncol. 2022;125:703-711.
    PubMed     Abstract available
    
    
    
71. KOLBEINSSON HM, Hoppe A, Walker J, Chandana S, et al
    Recurrence and survival after curative-intent treatment for colorectal liver metastases: Implications for adjuvant liver-directed regional chemotherapy.
    J Surg Oncol. 2022;125:664-670.
    PubMed     Abstract available
    
    
    February 2022
72. SUN Y, Yu D, Zhong J, Lin Y, et al
    Para-aortic lymph node dissection in left-sided colorectal cancer: Risk factors, prognostic impact, and therapeutic value.
    J Surg Oncol. 2022 Feb 24. doi: 10.1002/jso.26829.
    PubMed     Abstract available
    
    
    
73. HUANG Z, Cai P, Zhao Y, Niu D, et al
    Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
    J Surg Oncol. 2022 Feb 17. doi: 10.1002/jso.26823.
    PubMed     Abstract available
    
    
    
74. CUIJPERS ACM, Bongers BC, Heldens AFJM, Bours MJL, et al
    Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Feb 11. doi: 10.1002/jso.26817.
    PubMed     Abstract available
    
    
    
75. VALADAO M, Cesar D, Veo CAR, Araujo RO, et al
    Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer.
    J Surg Oncol. 2022;125:194-216.
    PubMed     Abstract available
    
    
    January 2022
76. ADACHI Y, Tokunaga R, Matsumoto K, Nakao Y, et al
    What are the factors predictive of postoperative complications in patients with colorectal cancer undergoing stenting as a bridge to surgery?
    J Surg Oncol. 2022 Jan 31. doi: 10.1002/jso.26803.
    PubMed     Abstract available
    
    
    
77. NARAYAN RR, Aveson VG, Chou JF, Walch HS, et al
    Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.
    J Surg Oncol. 2022 Jan 23. doi: 10.1002/jso.26797.
    PubMed     Abstract available
    
    
    
78. PARK LJ, Daza JF, Li V, Workneh A, et al
    Prognostic factors of overall survival in patients with recurrent disease following liver resection for colorectal cancer metastases: A multicenter external validation study.
    J Surg Oncol. 2022 Jan 20. doi: 10.1002/jso.26796.
    PubMed     Abstract available
    
    
    
79. FOSTER JM, Alexander HR, Zhang C
    Regional therapy trials in peritoneal metastases: The path to standardization-Colorectal cancer.
    J Surg Oncol. 2022;125:57-63.
    PubMed    
    
    
    
80. WHELAN S, Burneikis D, Kalady MF
    Rectal cancer: Maximizing local control and minimizing toxicity.
    J Surg Oncol. 2022;125:46-54.
    PubMed     Abstract available
    
    
    December 2021
81. CHODOFF A, Smith KC, Shukla A, Blackford AL, et al
    Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations.
    J Surg Oncol. 2021 Dec 11. doi: 10.1002/jso.26767.
    PubMed     Abstract available
    
    
    
82. SERRANO PE, Parpia S, Karanicolas P, Gallinger S, et al
    Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial.
    J Surg Oncol. 2021 Dec 8. doi: 10.1002/jso.26764.
    PubMed     Abstract available
    
    
    
83. KIM JC, Ha YJ, Park IJ, Kim CW, et al
    Tumor immune microenvironment of primary colorectal adenocarcinomas metastasizing to the liver or lungs.
    J Surg Oncol. 2021;124:1136-1145.
    PubMed     Abstract available
    
    
    
84. YANG W, Liu Q, Lin G, Zhang B, et al
    The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    J Surg Oncol. 2021;124:1128-1135.
    PubMed     Abstract available
    
    
    
85. YOON DH, Ibrahim A, Tatishchev S, Duldulao MPN, et al
    Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
    J Surg Oncol. 2021;124:1091-1097.
    PubMed     Abstract available
    
    
    
86. WANG Y, Zhang Y, Lin H, Xu M, et al
    Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
    J Surg Oncol. 2021;124:1098-1105.
    PubMed     Abstract available
    
    
    
87. LI Z, Wang Y, Ying X, Zhang L, et al
    Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
    J Surg Oncol. 2021;124:1356-1364.
    PubMed     Abstract available
    
    
    
88. MENG W, Yang B, Huang B, Chen C, et al
    Impact of preoperative transcatheter rectal arterial chemoembolization with concurrent chemoradiotherapy on surgery and prognosis of patients with locally advanced rectal cancer.
    J Surg Oncol. 2021;124:1451-1458.
    PubMed     Abstract available
    
    
    
89. DAMASCENO AM, Kesley R, Paolino BS, Dos Santos do Amaral MR, et al
    Perioperative score for octogenarian patients eligible for rectal cancer surgery.
    J Surg Oncol. 2021;124:1409-1416.
    PubMed     Abstract available
    
    
    
90. KAZI M, Jain D, Padhy AS, Menon M, et al
    Optimal neoadjuvant strategy for signet ring cell carcinoma of the rectum-Is TNT the solution?
    J Surg Oncol. 2021;124:1417-1430.
    PubMed     Abstract available
    
    
    November 2021
91. BRAJCICH BC, Benson AB, Gantt G, Eng OS, et al
    Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
    J Surg Oncol. 2021 Nov 25. doi: 10.1002/jso.26758.
    PubMed     Abstract available
    
    
    
92. HU Q, Sun YS, Yang XY
    Comment on "Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure".
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26580.
    PubMed    
    
    
    October 2021
93. NUMATA M, Shiozawa M, Godai T, Kazama K, et al
    Prediction of lateral lymph node metastasis using OSNA method for mesorectal lymph nodes in low rectal cancer: A prospective study by the Kanagawa Yokohama Colorectal Cancer Study Group (KYCC1801).
    J Surg Oncol. 2021 Oct 27. doi: 10.1002/jso.26730.
    PubMed     Abstract available
    
    
    September 2021
94. REUDINK M, Molenaar CJL, Bonhof CS, Janssen L, et al
    Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
    J Surg Oncol. 2021 Sep 27. doi: 10.1002/jso.26685.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: